-
Markeder
-
Aksjer
Sustainable finance2025 Euronext ESG Trends ReportLes merA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indekser
Access the white paperInvesting in the future of Europe with innovative indicesLes merThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETF-er
The European market place for ETFsEuronext ETF EuropeLes merInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fond
-
Obligasjoner
European Defence BondsGroupe BPCE lists the first bondLes merFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Strukturerte produkter
-
Derivater
Where European Government Bonds Meet the FutureFixed Income derivativesLes merTrade mini bond futures on main European government bonds
-
Råvarer
- Oversikt
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Levering og oppgjør
- Spesifikasjoner og ordninger
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLes merEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Ressurser
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLes merJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Observe Medical has today received a new significant order (1 MNOK) of UnoMeterT Safeti Plus from Central Europe
12 Dec 2024 15:55 CET
Oslo, December 12, 2024 - Observe Medical ("the Company" or "Observe Medical")
announces that the order intake of UnoMeterT SafetiT Plus has now reached 18
countries and brings the current order intake beyond NOK 5 million only 4 weeks
after the product was launched. The Company expects that this number will
continue to increase in the coming weeks. First deliveries are expected before
Christmas and will pick up speed in January and onwards.
Jørgen Mann, CEO of Observe Medical, commented, "We are seeing a continued
positive development in the order intake on our UnoMeterT portfolio, and
particularly on UnoMeterT SafetiT Plus. With the first deliveries starting
shortly we expect that we can continue taking back the historic market share of
the UnoMeterT family and thereby securing a strong distribution platform and
financial resources to support our ambition to become market leader within urine
output measurement".
For further information, please contact:
Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available at www.observemedical.com.
More information:
Access the news on Oslo Bors NewsWeb site
Kilde
Observe Medical ASA
Leverandør
Oslo Børs Newspoint
Company Name
OBSERVE MEDICAL
ISIN
NO0010865009, NO0013457952
Ticker
OBSRV
Marked
Euronext Expand